Effect of SNAGs and Scapular Mobilizations in Patients With Scapulocostal Syndrome

October 23, 2024 updated by: Riphah International University
To determine the impact of SNAGs and Scapular mobilizations on pain, cervical and shoulder Range of motion and functional outcomes in individuals with Scapulocostal Syndrome.

Study Overview

Detailed Description

The rationale for employing SNAGS (Sustained Natural Apophyseal Glides) in treating scapulocostal syndrome is multifaceted. By targeting specific joint surfaces and soft tissue structures, SNAGS aim to address joint dysfunction, alleviate pain, and improve mobility in the scapulothoracic region. These sustained gliding movements not only modulate pain signals but also promote relaxation and reduce muscle tension, thereby enhancing the effectiveness of therapeutic exercises aimed at strengthening the surrounding musculature. Additionally, SNAGS facilitate proper muscle activation patterns, optimizing muscle function and coordination. Their adaptability allows for a patient-centered approach, ensuring tailored treatment that considers individual symptoms, mobility deficits, and treatment goals, ultimately promoting better functional outcomes in individuals with scapulocostal syndrome.

Study Type

Interventional

Enrollment (Estimated)

36

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Punjab
      • Rawalpindi, Punjab, Pakistan, 44000
        • Recruiting
        • DSK physio and Rehab Center
        • Contact:
        • Contact:
        • Principal Investigator:
          • Rabia asif, MS-OMPT*
        • Sub-Investigator:
          • Asmar Fatima, MS-OMPT

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Age- 18 to 40 years.

    • Male and female both
    • Nonspecific neck pain with a duration of greater than 3 months
    • No pain reproduction on isometric muscle testing in shoulder.
    • Patients who could not achieve 60 degrees of upward rotation when elevating the arms above the head i.e. presence of scapular dyskinesia
    • pain with a referral pattern while receiving manual pressure of at least 3 points on the medial scapular muscles (levator scapulae, rhomboid major, rhomboid minor, and serratus posterior superior) evaluated through Travels and Simon criteria.
    • Discomfort, pain, or limitations in neck extension, neck rotation bilaterally, shoulder forward flexion, shoulder abduction attributed to SCS.
    • Willing to provide informed consent to participate in the study.

Exclusion Criteria:

  • Musculoskeletal pathologies affecting the cervical spine or lower extremities (e.g., herniated disc, cervical radiculopathy, cervical stenosis, shoulder labral tear).

    • history of degenerative shoulder joint disease
    • rotator cuff dysfunction
    • Thoracic outlet syndrome
    • Brachial neuralgia
    • shoulder impingement syndrome
    • adhesive capsulitis
    • Pregnant individuals due to potential discomfort.
    • Open wounds, infections, or skin conditions at pain site.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Cervical and Thoracic SNAGs
Cervical and Thoracic SNAGs with 6 reps and 1 set along with cervical and shoulder muscle stretching and scapular mobilizations
cervical SNAGs (C3-C7) and thoracic SNAGs (T1-T12) with 6 repetitions of 1 set three times per week for 4 weeks along with scapular mobilizations of 10 repetitions of 1 set and stretching of trapezius (upper, middle and lower fibers), levator scapulae and rhomboids (major and minor)
Active Comparator: traditional physical therapy and scapular mobilizations
cervical and shoulder muscle stretching and scapular mobilizations
scapular mobilizations of 10 repetitions of 1 set and stretching of trapezius (upper, middle and lower fibers), levator scapulae and rhomboids (major and minor)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Neck disability index
Time Frame: 4th week

changes from baseline The Neck Disability Index (NDI) serves as a valuable tool for evaluating neck pain issues, drawing on the framework of the Oswestry index for back pain and the Pain Disability Index. Its effectiveness lies in its focus on the impact of neck pain on daily activities, reflecting the specific concerns and experiences of individual patients.

Comprising 10 sections, each containing 5 questions related to affected activities, the index allows patients to select the response that best represents their situation, with scores ranging from 0 to 5.

4th week

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
NPRS
Time Frame: every week
changes from baseline Pain through NPRS at the end of every week for 4 weeks
every week
Cervical and Shoulder ROM
Time Frame: every week
changes from baseline at the end of every week till last week
every week

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Asmar Fatima, MS-PT, Riphah International University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 1, 2024

Primary Completion (Estimated)

March 31, 2025

Study Completion (Estimated)

March 31, 2025

Study Registration Dates

First Submitted

October 23, 2024

First Submitted That Met QC Criteria

October 23, 2024

First Posted (Actual)

October 24, 2024

Study Record Updates

Last Update Posted (Actual)

October 24, 2024

Last Update Submitted That Met QC Criteria

October 23, 2024

Last Verified

October 1, 2024

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • REC/MS-PT/01941 Rabia Asif

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Scapulocostal Syndrome

Clinical Trials on Cervical and Thoracic SNAGs

Subscribe